ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselUltragenyx Europe GmbH
Ultragenyx Europe GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Ultragenyx Europe GmbH is a biopharmaceutical company that develops therapies for rare and ultra-rare genetic diseases and researches multiple drug modalities, including gene therapy. The company maintains a clinical pipeline, provides approved medicines such as DOJOLVI and MEPSEVII, and operates patient support programs.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Ultragenyx Europe GmbH

✓ Offered6
Medicines for rare and ultra-rare genetic diseases
Drug development and marketing for rare and ultra-rare genetic diseases, including approved therapies and further treatment options across multiple indications.
Research and development programmes for rare diseases
Research programmes for rare and ultra-rare genetic diseases with biologics, small molecules, gene therapies and ASO approaches, as well as clinical study development.
Clinical studies
Clinical studies of investigational therapies, including participation information and references to ongoing studies for patients and physicians.
Patient access to therapies (UltraCare)
Patient programmes to support access to treatments, including help with insurance, financial support and patient assistance programmes.
Early access to investigational therapies
Early access to investigational therapies for certain patients with severe or immediately life-threatening disease, on a case-by-case basis and under certain conditions.
Partnerships and licensing
Partnership and licensing models for the development and commercialisation of rare-disease therapies and platform technologies with academic and biopharma partners.
Trust & reputation

ranQ Trust Score of Ultragenyx Europe GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Ultragenyx Europe GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Ultragenyx Europe GmbH scores 80.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.86.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Ultragenyx Europe GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Ultragenyx Europe GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Ultragenyx Europe GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Ultragenyx Europe GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Ultragenyx Europe GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Ultragenyx Europe GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Ultragenyx Europe GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lichtstrasse 35
4056 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-357.652.851
Founded
2016 · 10 years
Last commercial register change
December 18, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    VT
    Vaderis Therapeutics AG
    Basel
    RM
    Revolution Medicines Switzerland GmbH
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel
    SL
    S. L. A. Pharma AG
    Basel
    AP
    Acadia Pharmaceuticals GmbH
    Basel
    IC
    ICON Clinical Research (Switzerland) GmbH
    Basel
    AS
    Autolus Switzerland AG
    Basel
    AS
    Azafaros Switzerland AG
    Basel